Clinical Trial Update: A Study to Decrease Suicidal Thinking Using Ketamine [Phase 3]

View source ↗

Summary

Phase 3 clinical trial investigating ketamine to decrease suicidal thinking in depression was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder
• Suicide

Drugs mentioned

• Ketamine (ketamine)

Snippet

Sponsor: United States Naval Medical Center, San Diego | Conditions: Depression, Suicide | Phase 3 | Status: WITHDRAWN